Literature DB >> 16445446

Visual outcomes with the yellow intraocular lens.

Igal Leibovitch1, Tze Lai, Neroli Porter, George Pietris, Henry Newland, Dinesh Selva.   

Abstract

PURPOSE: To compare postoperative best distance visual acuity (VA), contrast sensitivity and colour perception with the blue light-filtering AcrySof Natural (SN60AT) and AcrySof single-piece (SA60AT) intraocular lenses (IOLs).
METHODS: This was a prospective, randomized, comparative, interventional study comparing postoperative performance between the SN60 and SA60 IOLs. There were nine patients (nine eyes) in the SN60 group and 10 patients (10 eyes) in the SA60 group. All patients were operated using phacoemulsification. Postoperative VA (Snellen chart), contrast sensitivity (Pelli-Robson contrast sensitivity chart) and colour perception (Farnsworth-Munsell D-15 panel test) were measured at 1, 3 and 6 months postoperatively.
RESULTS: Postoperative best corrected VA after 6 months was 20/20 or better in 89% of SN60 eyes and 100% of SA60 eyes. Postoperative contrast sensitivity scores improved significantly in both groups under both photopic and mesopic conditions. There were no statistically significant differences in contrast sensitivity scores between the SN60 and SA60 groups at any of the postoperative evaluation time-points. Postoperative colour perception improved significantly in both the SN60 and SA60 groups, and there were no statistically significant differences in colour perception performance between the two groups.
CONCLUSION: The blue light-filtering AcrySof Natural (SN60) IOL has postoperative visual performance comparable with that of the AcrySof single-piece (SA60) IOL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16445446     DOI: 10.1111/j.1600-0420.2005.00607.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  9 in total

1.  The effect of chromatic dispersion on pseudophakic optical performance.

Authors:  Huawei Zhao; Martin A Mainster
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

2.  Clinical comparative analysis of the outcomes with a yellow- and a violet-tinted intraocular lens.

Authors:  Peter Mojzis; Zdenek Bombera; Sarka Vesela; Daniela Klapuchova; Peter Ziak; David P Piñero
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

3.  Blue-light-blocking intraocular lens implantation improves the sleep quality of cataract patients.

Authors:  Xin Wei; Chunyan She; Danian Chen; Fangbing Yan; Jihong Zeng; Liping Zeng; Lin Wang
Journal:  J Clin Sleep Med       Date:  2013-08-15       Impact factor: 4.062

Review 4.  Recent studies provide an updated clinical perspective on blue light-filtering IOLs.

Authors:  James A Davison; Anil S Patel; Joao P Cunha; Jim Schwiegerling; Orkun Muftuoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-17       Impact factor: 3.117

Review 5.  Comparison of blue light-filtering IOLs and UV light-filtering IOLs for cataract surgery: a meta-analysis.

Authors:  Xiao-feng Zhu; Hai-dong Zou; Yong-fu Yu; Qian Sun; Nai-qing Zhao
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

6.  Aspheric versus Spherical Posterior Chamber Intraocular Lenses.

Authors:  Mohammad-Reza Jafarinasab; Sepehr Feizi; Ahmad-Reza Baghi; Hossein Ziaie; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2010-10

Review 7.  Blue-light filtering intraocular lenses (IOLs) for protecting macular health.

Authors:  Laura E Downie; Ljoudmila Busija; Peter R Keller
Journal:  Cochrane Database Syst Rev       Date:  2018-05-22

8.  Blue-Light Filtering Spectacle Lenses: Optical and Clinical Performances.

Authors:  Tsz Wing Leung; Roger Wing-Hong Li; Chea-Su Kee
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

9.  Patient-Reported Difference following Implantation of a Blue Light-Filtering Aspheric Intraocular Lens and a UV-Filtering Aspheric Intraocular Lens.

Authors:  Cédric Schweitzer; Joseph Colin
Journal:  Case Rep Ophthalmol       Date:  2013-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.